Drug Discovery and Early Development Outsourcing Services Industry Analysis – M&As, Partnerships and the Shift Toward an End-to-end CRDMO Model will Boost Sector Expansion – ResearchAndMarkets.com
Digital Health Global
APRIL 5, 2024
DUBLIN–(BUSINESS WIRE)–The “Growth Opportunities in Drug Discovery and Early Development Outsourcing Services” report has been added to ResearchAndMarkets.com’s offering. hike over 2022, with more than 6,100 molecules in active development. growth between 2023 to 2024.
Let's personalize your content